生物技术市场规模、份额、增长| 2025年分析

  • Report Code : TIPHE100001316
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 141
Buy Now

[研究报告]生物技术市场规模预计将从2017年的2180.121亿美元增至2025年的4713.364亿美元;预计 2017 年至 2025 年复合年增长率为 10.5%。

市场洞察和分析师观点:

生物技术用于各种应用,包括工业/生物加工、生物信息学、食品和医疗保健。农业、健康、自然资源和环境等。此外,现代生物技术能够为对抗难以忍受的罕见疾病的产品和技术提供出色的创新,它还可以减少环境足迹,养活饥饿的人。此外,它利用更少、更清洁的能源来实现更安全、更清洁和更高效的工业制造过程。基因组测序价格下降、创新技术不断增加等因素促进了生物技术市场的增长。此外,私人和政府机构越来越多的举措也推动了生物技术市场的增长。此外,未来会议和研讨会的不断增加预计将成为未来生物技术市场的趋势。        

增长动力和挑战:

信息学专家和生物学家使用更新的测序技术,旨在制造更好的基因组。近年来,用于将 DNA 拼接在一起的软件技术不断改进,用于定位染色体序列的新技术也不断增加。为了支持采用改进的工具和技术的新技术,制定了多个计划。例如,1989 年,国家人类基因组研究所 (NHGRI) 的基因组测序计划成立,旨在解决当前基因组学的科学机遇。

基因组技术计划也是支持开发具有改进方法和仪器的新技术,以实现低成本快速测定 DNA 序列、功能基因组学实验和 SNP 基因分型。基因组技术计划还支持从开发人员到用户的技术转让,并有助于促进与工业和学术实验室紧密结合的协作性多学科计划。此外,许多行业参与者在过去几年中提出了创新的NGS技术。例如,Pacific Biosciences 的 Sequel 以及 Oxford Nanopore 的 PromethION。此外,主导市场的三种先进 NSG 系统包括 Roche GS FLX (454)、Illumina HiSeq 2000 (Solexa) 和 AB SOLiD (Agencourt)。基因组测序的进步使测序变得简单而准确。

因此,由于技术进步,生物技术市场预计将快速增长。

战略见解

生物技术市场细分和范围:

“全球生物技术市场”根据技术、应用和地理位置进行细分。生物技术市场按技术分为 DNA 测序、发酵、细胞分析、纳米生物技术、色谱、PCR 技术、组织工程和再生以及其他技术。根据应用,生物技术市场分为工业加工、生物信息学、食品和生物技术。农业、健康、自然资源和环境、其他应用。基于地理位置的生物技术市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度、南美)韩国、亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美和非洲中美洲(巴西、阿根廷以及南美洲和中美洲其他地区)

细分分析:

根据产品,生物技术市场分为 DNA 测序、发酵、细胞检测、纳米生物技术、色谱、PCR 技术、组织工程和再生以及其他技术。 DNA 测序领域在 2017 年占据了最大的市场份额,并且该领域可能在预测期内以最高的速度增长。 DNA 测序是一种用于确定形成 DNA 链的核苷酸碱基特定顺序的技术。目前,它是许多基础和应用研究及其应用的重要技术。 DNA测序技术被用于历时十三年完成的人类基因组计划,有助于了解遗传病基因变化的原因。该技术还有助于针对特定基因,可用于设计针对特定遗传疾病的药物。此外,DNA测序还用于亲子关系和其他家庭关系的基因检测。此外,DNA测序还用于通过法医研究来识别犯罪嫌疑人和受害者。此外,这些技术在分析细菌和其他污染空气、水和食物的微生物方面也发挥着重要作用。 DNA测序主要用于识别和研究不同类群动植物的变异及其迁徙模式,以确定种子或牲畜的稀有品种。 Thermo Fisher Scientific Inc.、Merck KGaA、Illumina, Inc. 等许多公司以及其他各种初创公司为 DNA 测序技术提供各种试剂盒和试剂。因此,DNA 测序所提供的优势及其在上述应用中的使用预计将在预测期内推动该细分市场的增长。

根据应用,生物技术市场分为工业加工、生物信息学、食品和生物技术。农业、健康、自然资源和环境、其他应用。 2017年工业加工领域占据最大市场份额;而生物信息学领域在预测期内可能会以更高的速度增长。工业加工或生物加工市场是生物技术最有前途的领域之一,它对医疗保健和农业生物技术市场产生了重大影响,也是预防污染和保护资源的新方法。工业加工或生物加工市场提供的业务可以降低成本并通过破坏环境来创造新市场。生物技术中的大多数实验室研究都是为了商业应用。这些应用程序用于药物发现和药物开发。治疗性人类蛋白质的开发是通过重组方法完成的。例如,重组人胰岛素是Genetech于1982年生产并销售的第一个重组药物。糖尿病患病率的上升为重组胰岛素带来了巨大的利润,并在未来的生物技术市场中具有显着的增长。此外,工业加工的应用包括生产酶和微生物,以在化学品、食品配料、洗涤剂、纸张、纺织品、饮料、织物、塑料、个人护理、生物燃料等领域制造生物基产品。

工业加工下的药物开发过程涉及多种过程。发现和开发等步骤是第一步,接下来是临床前研究、临床研究、FDA审查,最后是FDA上市后安全监测。许多生物制药公司参与药物开发过程。药物发现和开发的主要产品是由各个生物技术公司提供的蛋白质。许多公司都参与了可用于治疗肝炎、癌症和心脏病等疾病的生物制药的扩展。这些疾病的流行可能迫使生物技术公司生产更多药物开发所需的原材料,因此,这些公司更加积极地进行实验室研究。因此,考虑到生物技术在工业加工中的应用可能会在不久的将来显着增长。

生物技术市场(按产品)– 2017年和2025年

区域分析:

根据地理位置,生物技术市场分为五个关键区域:北美、欧洲、亚太地区、南美洲和南美洲。中美洲、中东和非洲非洲。 2017年,北美在全球生物技术市场中占据最大份额,预计亚太地区在预测期内的复合年增长率最高。北美是最大的生物技术市场,其中美国占据最大的市场份额,其次是加拿大。北美增长的特点是生物制药和生物技术公司对创新产品的需求增加、主要市场参与者的存在以及各个学术和研究机构进行的广泛研发。此外,越来越多地关注医疗保健中先进方法的整合、政府和私人促进精准医疗的举措以及政府和私人机构为基因组研究提供的大量资金,预计将进一步刺激北美生物技术市场的增长并为其带来非凡的收入。 。由于各种开发计划和商业策略,通过生物工程方法帮助生产、发现或改变各种生物分子和有机体,医疗和农业生物技术经历了革命。

此外,美国生物技术行业仍然是全球基准,被认为是增长最快和成功的市场之一,在可预见的未来可能会保持其地位。科学技术的进步以及对潜在机制的不断了解正在支持美国利用生物技术方法为患者开发新疗法。仿生眼、3D打印器官、生物电癌症检测只是该国过去几年在生物技术领域取得的一些重大进展。此外,据《美国医学会杂志》报道,美国的医疗保健支出是世界其他高收入国家的两倍。

生物技术创业革命也推动了美国医疗保健支出的增长。协助促进该地区拥有有前景和创新理念的新企业,并支持最大限度地创造收入,从而提高北美在全球生物技术市场中的全球经济地位。

行业发展及未来机遇:

全球生物技术市场主要参与者采取的各种举措如下:

  1. 2022 年 4 月,CytoTronics 筹集了 925 万美元的初始种子资金,由 Anzu Partners 牵头,Milad Alucozai (BoxOne Ventures) 和机构投资者协会联合。该公司将利用这笔种子资金来推广其创新平台,该平台利用计算机芯片技术进行基于细胞的电气和电化学检测。
  2. 2021 年 6 月,Element 在 C 轮融资中筹集了 2.76 亿美元用于 DNA 测序平台。该测序平台旨在降低基因组应用的成本,同时通过重组 DNA 测序系统的基本要素(包括供研究和诊断用户使用的测序化学、表面化学、检测和数据分析)大幅提高质量。< li>2021 年 2 月,Selvita 推出了用于药物发现的新的基于细胞的表型测定平台。该平台将用于测试在神经炎症、纤维化疾病等多个领域具有治疗潜力的新化合物,解决现有治疗方法的具体限制。该平台将使 Selvita 能够通过一种新颖、强大的方法来补充其综合药物发现服务组合,以快速有效地发现和开发新药。
  3. 2021 年 12 月,Thermo Fisher Scientific Inc. 宣布以 174 亿美元完成对 PPD, Inc. 的收购,PPD, Inc. 是一家为生物制药和生物技术行业提供临床研究服务的全球领先提供商。

Covid-19 影响:

COVID-19 大流行对生物技术市场产生了积极影响。公司正在开发新的治疗方案来对抗 COVID-19 疫情。例如,2020 年 12 月,赛默飞世尔科技 (Thermo Fisher Scientific) 宣布其 TaqPath COVID-19、Flu A/B、呼吸道合胞病毒 (RSV) 组合试剂盒获得 CE 标志,用于体外诊断 SARS-CoV-2、RSV A/ B 型感染和 A/B 型流感。

针对 COVID-19 感染的药物开发和疫苗制造方面的进步和机会有所增加。例如,根据国际药品制造商和协会联合会 (IFPMA) 的数据,全球生产了超过 110 亿剂的 COVID-19 疫苗,从而形成了全球最大的免疫计划。此外,mRNA 疫苗的繁荣和审批流程的加快导致疫苗相关收入激增,辉瑞/BioNTech 和强生公司 2021 年联合创收约 310 亿美元就证明了这一点。约翰逊莫德纳疫苗。

竞争格局和主要公司:

全球生物技术市场的一些知名企业包括 Thermo Fisher Scientific Inc.、Merck KGaA、F. Hoffmann-La Roche Ltd、PerkinElmer Inc.、Danaher、QIAGEN、Agilent Technologies、BD、Bio-Rad Laboratories, Inc. 和Illumina, Inc. 这些公司专注于新产品发布和地域扩张,以满足全球不断增长的消费者需求并增加其专业产品组合的产品范围。他们在全球范围内拥有广泛的业务,这使他们能够为大量客户提供服务,从而提高他们的市场份额。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR growth in the forecast period?

The biotechnology in healthcare market is projected to reach US$ 471,336.4 million by 2027; it is expected to grow at a CAGR of 10.5%

What is the forecast period in this market report?

The forecast period of biotechnology in healthcare market is 2017 - 2025.

What is the key factor driving the biotechnology market?

Key factors that are driving the growth of this market are the declining prices of genome sequencing, increasing innovative technologies, increasing number of initiatives by private and government bodies.

What are the restraining factors for biotechnology market across the globe?

Factors such as risks associated with genetic data and systemic risks of genetically modified crops are likely to restrain the market growth to a certain extent.

Which segment is fastest growing?

As per Technology based insights, the nanotechnology segment is fastest growing segment and is accounted to grow at the CAGR of 13.2%.

Which is the largest segment among technology segment?

The DNA sequencing is the largest segment among the technology segment in the biotechnology market in 2017 and is also anticipated to hold the largest market in the year 2025.

The List of Companies

1. Thermo Fisher Scientific Inc.
2. Merck KGaA
3. PerkinElmer, Inc.
4. Agilent Technologies, Inc.
5. F. Hoffmann-La Roche Ltd.
6. Danaher
7. QIAGEN
8. BD
9. Bio-Rad Laboratories, Inc.
10. Illumina, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports